NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.

As a result, the Louisville, Ky.-based company can offer its testing services in all 50 states in the US, it said. According to PGXL's website, it provides pharmacogenetic tests for CYP2C19, CYP2D6, Factor V Leiden, Factor II, and others. It also offers molecular oncology testing for the detection of EGFR, HER2/neu (fluorescent in situ hybridization), JAK2, ALK (FISH), and other genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.